Literature DB >> 2015366

Langerhans cells and T lymphocyte subsets in the murine vagina and cervix.

M B Parr1, E L Parr.   

Abstract

Immunization in the vagina can lead to the production of specific antibodies in the luminal fluid of this organ. To help understand the immune mechanisms involved in this process, we have studied the occurrence of Langerhans cells (LCs), macrophages, natural killer cells, and T and B lymphocytes in the murine vagina and cervix during the estrous cycle. LCs in the epithelia expressed Ia, F4/80, NLDC-145, and CD45, but not Mac-1, Moma-1, and Moma-2; double-labeling demonstrated phenotypic heterogeneity in this population Ia+, NLDC-145+; Ia+, NLDC-145-; Ia+, F4/80+; Ia+, F4/80-; Ia- F4/80+. T lymphocytes of both helper and cytotoxic/suppressor types were also present in the epithelia, sometimes in close association with LCs, but natural killer cells were not observed. The stroma of the vagina and cervix contained LCs (or interdigitating cells) and macrophages but few T lymphocytes and no B lymphocytes, natural killer cells, or lymphoid nodules. These observations confirm and extend previous reports that the murine vagina and cervix contain epithelial LCs and T lymphocytes and support the suggestion that antigens in the vagina and cervix, as in the epidermis, may be recognized and presented to the immune system by epithelial LCs. However, the paucity of T cells and the absence of B cells and lymphoid nodules from the stroma suggest that antigen presentation may not occur locally but at another site such as in the draining lymph nodes.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2015366     DOI: 10.1095/biolreprod44.3.491

Source DB:  PubMed          Journal:  Biol Reprod        ISSN: 0006-3363            Impact factor:   4.285


  26 in total

1.  Evidence for a unique expression of CD4 on murine vaginal CD4+ cells.

Authors:  F L Wormley; M Scott; W Luo; M Baker; J Chaiban; P L Fidel
Journal:  Immunology       Date:  2000-07       Impact factor: 7.397

2.  Cell adhesion molecule and lymphocyte activation marker expression during experimental vaginal candidiasis.

Authors:  F L Wormley; J Chaiban; P L Fidel
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

3.  Vaginal epithelial dendritic cells renew from bone marrow precursors.

Authors:  Norifumi Iijima; Melissa M Linehan; Sem Saeland; Akiko Iwasaki
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-15       Impact factor: 11.205

4.  Local production of chemokines during experimental vaginal candidiasis.

Authors:  M Saavedra; B Taylor; N Lukacs; P L Fidel
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

Review 5.  Cytokines in the host response to Candida vaginitis: Identifying a role for non-classical immune mediators, S100 alarmins.

Authors:  Junko Yano; Mairi C Noverr; Paul L Fidel
Journal:  Cytokine       Date:  2011-12-17       Impact factor: 3.861

6.  Antigen-presenting cells in the female reproductive tract: influence of sex hormones on antigen presentation in the vagina.

Authors:  C R Wira; R M Rossoll
Journal:  Immunology       Date:  1995-04       Impact factor: 7.397

7.  Immunity to Chlamydia trachomatis mouse pneumonitis induced by vaccination with live organisms correlates with early granulocyte-macrophage colony-stimulating factor and interleukin-12 production and with dendritic cell-like maturation.

Authors:  D Zhang; X Yang; H Lu; G Zhong; R C Brunham
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

Review 8.  Dendritic cells and macrophages in the genitourinary tract.

Authors:  N Iijima; J M Thompson; A Iwasaki
Journal:  Mucosal Immunol       Date:  2008-09-10       Impact factor: 7.313

9.  Candida-specific antibodies during experimental vaginal candidiasis in mice.

Authors:  Karen L Wozniak; Floyd L Wormley; Paul L Fidel
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

Review 10.  Dendritic cells and vaccine design for sexually-transmitted diseases.

Authors:  Dorothee Duluc; Julien Gannevat; Hyemee Joo; Ling Ni; Katherine Upchurch; Muriel Boreham; Michael Carley; Jack Stecher; Gerard Zurawski; Sangkon Oh
Journal:  Microb Pathog       Date:  2012-11-29       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.